This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Shenoy S, Eapen M, Panepinto JA, Logan BR, Wu J, Abraham A, et al. A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. Blood. 2016;128:2561–7.
Kamani NR, Walters MC, Carter S, Aquino V, Brochstein JA, Chaudhury S, et al. Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biol Blood Marrow Transplant. 2012;18:1265–72.
Adler BK, Salzman DE, Carabasi MH, Vaughan WP, Reddy VV, Prchal JT. Fatal sickle cell crisis after granulocyte colony-stimulating factor administration. Blood. 2001;97:3313–4.
Fitzhugh CD, Hsieh MM, Bolan CD, Saenz C, Tisdale JF. Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium? Cytotherapy. 2009;11:464–71.
Dudley AW Jr, Waddell CC. Crisis in sickle cell trait. Hum Pathol. 1991;22:616–8.
Gereklioglu C, Asma S, Korur A, Tepebasi S, Aytan P, Yeral M, et al. Granulocyte-colony stimulating factor administration among hemoglobin S trait donors: a single center experience from the Eastern Mediterranean region. J Clin Apher. 2018;33:65–71.
Al-Khabori M, Al-Ghafri F, Al-Kindi S, Al-Riyami AZ, Al-Farsi K, Al-Huneini M, et al. Safety of stem cell mobilization in donors with sickle cell trait. Bone Marrow Transplant. 2015;50:310–1.
Kang EM, Areman EM, David-Ocampo V, Fitzhugh C, Link ME, Read EJ, et al. Mobilization, collection, and processing of peripheral blood stem cells in individuals with sickle cell trait. Blood. 2002;99:850–5.
Favre G, Beksac M, Bacigalupo A, Ruutu T, Nagler A, Gluckman E, et al. Differences between graft product and donor side effects following bone marrow or stem cell donation. Bone Marrow Transplant. 2003;32:873–80.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Damlaj, M., Alaskar, A., Ghazi, S. et al. Peripheral hematopoietic stem cell mobilization utilizing growth factors in donors with sickle cell trait is safe and effective. Bone Marrow Transplant 53, 1366–1368 (2018). https://doi.org/10.1038/s41409-018-0208-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-018-0208-3